| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.6M | +39.6% |
| R&D Expense | $32.4M | +2.4% |
| SG&A Expense | $13.5M | -5.0% |
| Operating Income | -$44.8M | +0.5% |
| Income Tax | $0 | — |
| Net Income | -$44.4M | +2.0% |
| EPS (Basic) | -$0.50 | +5.7% |
| EPS (Diluted) | -$0.50 | +5.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $38.3M | -52.5% |
| Current Assets | $40.3M | -51.0% |
| Total Assets | $42.2M | -50.3% |
| Current Liabilities | $13.6M | +2.5% |
| Total Liabilities | $61.2M | -3.2% |
| Stockholders' Equity | -$19.1M | -188.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$42.4M | -4.5% |
| Capital Expenditures | $17K | +54.5% |
| Investing Cash Flow | -$55K | -101.0% |
| Financing Cash Flow | $73K | -99.9% |
| Free Cash Flow | -$42.4M | -4.5% |